US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% META $728.08 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00% NVDA $233.95 ▲+0.00% JNJ $256.03 ▲+0.00% SNDK $1,719.99 ▲+0.00%
FinancialContent

Articles published by Turn Therapeutics Inc.

News headline image
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences
From Turn Therapeutics Inc.
Via Business Wire
Tickers TTRX